BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 792350)

  • 1. A simple method for isolation of human properdin by affinity chromatography.
    Konno T; Hirai H
    J Immunol Methods; 1976; 12(1-2):47-55. PubMed ID: 792350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the immunochemical properties of highly purified properdin in human serum.
    Minta JO
    J Immunol; 1975 Apr; 114(4):1415-21. PubMed ID: 123262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of Guinea pig properidin.
    Nicholson A; Austen KF
    J Immunol; 1977 Jan; 118(1):103-8. PubMed ID: 830742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of native properdin by reversed affinity chromatography and its activation by proteolytic enzymes.
    Minta JO
    J Immunol; 1976 Aug; 117(2):405-12. PubMed ID: 950461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    Stitzel AE; Spitzer RE
    J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification and some properties of a heat labile serum factor (UP); identity with glycine-rich beta-glycoprotein and properdin factor B.
    Lynen R; Brade V; Wolf A; Vogt W
    Hoppe Seylers Z Physiol Chem; 1973 Jan; 354(1):37-47. PubMed ID: 4214745
    [No Abstract]   [Full Text] [Related]  

  • 7. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
    Naff GB; Hedrick SW; Ratnoff WD; Novak MA; Smith MC; Steiner C; Todd EW
    J Immunol; 1980 Jun; 124(6):2625-31. PubMed ID: 6900053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of properdin in the alternate pathway of complement activation.
    Götze O; Müller-Eberhard HJ
    J Exp Med; 1974 Jan; 139(1):44-57. PubMed ID: 4808709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.
    LEON MA
    J Exp Med; 1957 May; 105(5):403-15. PubMed ID: 13428911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative pathway of complement: nonenzymatic, reversible transition of precursor to active properdin.
    Götze O; Medicus RG; Müller-Eberhard HJ
    J Immunol; 1977 Feb; 118(2):525-32. PubMed ID: 839069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EVIDENCE FOR IMMUNOLOGICAL SPECIFICITY OF THE PROPERDIN SYSTEM; DEMONSTRATION, ISOLATION AND PROPERTIES OF A SERUM FACTOR WHICH INTERACTS WITH ZYMOSAN AND OTHER POLYSACCHARIDES AT 0 DEGREES CENTIGRADE.
    BLUM L
    J Immunol; 1964 Jan; 92():61-72. PubMed ID: 14139548
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification of alpha-2 macroglobulin by immunoadsorbent chromatography.
    McEntire JE
    J Immunol Methods; 1978; 24(1-2):39-45. PubMed ID: 82589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
    Brade V; Nicholson A; Lee GD; Mayer MM
    J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NATURAL INNATE IMMUNITY FOR BRUCELLA MELITENSIS. I. RELATION WITH PROPERDIN, COMPLEMENT, BACTERICIDAL PROPERTIES OF SERUM AND THE FORMATION OF SPECIFIC ANTIBODIES].
    LEON AP; OSOLLO G; CANO C
    Rev Inst Salubr Enferm Trop; 1962 Dec; 22():145-72. PubMed ID: 14076958
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparation of properdin by affinity chromatography.
    Ogle CK; Ogle JD; Alexander JW
    Immunochemistry; 1977 May; 14(5):341-4. PubMed ID: 598861
    [No Abstract]   [Full Text] [Related]  

  • 17. Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement.
    Ferreira VP; Cortes C; Pangburn MK
    Immunobiology; 2010 Nov; 215(11):932-40. PubMed ID: 20382442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of rabbit properdin of the alternative complement pathway.
    Nakano Y; Matsuda T; Sakamoto T; Tomita M
    J Immunol Methods; 1986 Jun; 90(1):77-83. PubMed ID: 3635564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immuno-electrophoretic studies on properdin-zymosan and properdin-inulin complex; an analysis of electrophoretic and immunologic behavior of properdin].
    SCHEIFFARTH F; FRENGER W; GOTZ H
    Klin Wochenschr; 1958 Apr; 36(8):367-9. PubMed ID: 13550834
    [No Abstract]   [Full Text] [Related]  

  • 20. Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.
    Brade V; Nicholson A; Bitter-Suermann D; Hadding U
    J Immunol; 1974 Dec; 113(6):1735-43. PubMed ID: 4279261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.